Humans cannot live without sleep and will suffer from some immediate backlash if they ignore the primal urge to shut their eyes. In a recent Ted-Ed lesson, neuroscientist Dr. Claudia Aguirre outlined the physical, mental, and emotional consequences that could emerge from sleep deprivation. Adults need seven to eight hours of sleep a day, while babies need at least… Continue reading By ICIM Member John Ghuneim MD: Brain Sleep Deprivation’s Negative Impacts On The Human Body; How Sleep Restores The Brain
Tag: NIH
Alternatives to Cancer, Inc.
A conference coming up in April reminds us that there is a lot going on in integrative cancer treatments.
A Natural, Nutrition-Based Breakthrough Treatment for Pancreatic Cancer?
A new book explains how the system trashed the groundbreaking NIH/National Cancer Institute clinical trial on this extremely promising therapy.
New Studies Turn the Tables on What’s Safe—and What’s Not
FDA finds higher levels of arsenic in chicken than previously thought; latest report reaffirms supplement safety; and NIH abandons niacin study.
An Epidemic of Type II Diabetes
Seven to eight years ago a NIH-grant request from Washington U. to study Ginseng and type II diabetes treatment noted that by the end of the decade up to 10% of the U.S. would be type II diabetic and as many as 40% of Americans pre-diabetic. As 2010, the end of the decade, draws to… Continue reading An Epidemic of Type II Diabetes
The TACT / NIH Chelation Study Has Resumed
The June 16 edition of Pulse of Health Freedom discussed the suspension of the NIH-sponsored clinical trial for chelation therapy known as the TACT study. The study’s investigators and coordinators have now been notified to resume all TACT activities, including the chelation infusions, patient follow-up, and vitamin distribution.
Update on the NIH Chelation Trial
The federal Trial to Assess Chelation (TACT) study is once again enrolling heart attack survivors. The study’s leader, Dr. Gervasio Lamas of the Mt. Sinai Medical Center in Miami, voluntarily suspended enrollment last fall after allegations were published in Medscape critical of the consent form given to patients and of the safety of the trial.The… Continue reading Update on the NIH Chelation Trial
FDA Petition Calls for Changes in Diabetes Drug Labeling
On December 18, a petition was filed with the FDA by the Physicians Committee for Responsible Medicine. It asks the FDA to require that diabetic medications in the thiazolidinedione class of drugs like Avandia include labeling that states a low-fat vegan diet has been shown to be as effective or more effective than medications taken… Continue reading FDA Petition Calls for Changes in Diabetes Drug Labeling
Diabetes Rate Up 90 Percent in Last Ten Years; Diabetes Spending Doubles in Just Six Years
Can the Public Health Effort Do More?